Investment Analysts’ Price Target Changes for June 8th (BBD.B, BOS, COO, EIF, MAL, MDA, NRIX, ROOT, SAP, TCL.A)

Investment Analysts’ price target changes for Monday, June 8th:

Bombardier, Inc. Class B (TSE:BBD.B) had its target price raised by TD from C$284.00 to C$292.00. TD currently has a hold rating on the stock.

AirBoss of America (TSE:BOS) had its target price increased by TD from C$9.00 to C$10.00. They currently have a buy rating on the stock.

Cooper Companies (NASDAQ:COO) had its price target trimmed by BNP Paribas Exane from $95.00 to $92.00. The firm currently has an outperform rating on the stock.

Exchange Income (TSE:EIF) had its target price increased by TD from C$125.00 to C$142.00. The firm currently has a buy rating on the stock.

Magellan Aerospace (TSE:MAL) had its price target increased by TD from C$30.00 to C$37.00. The firm currently has a buy rating on the stock.

MDA Space (TSE:MDA) had its price target increased by Desjardins from C$55.00 to C$66.00. Desjardins currently has a buy rating on the stock.

Nurix Therapeutics (NASDAQ:NRIX) had its target price cut by Wells Fargo & Company from $28.00 to $25.00. They currently have an overweight rating on the stock.

Nurix Therapeutics (NASDAQ:NRIX) had its target price raised by Jefferies Financial Group Inc. from $41.00 to $45.00. The firm currently has a buy rating on the stock.

Roots (TSE:ROOT) had its price target raised by TD from C$4.25 to C$4.50. They currently have a hold rating on the stock.

Saputo (TSE:SAP) had its price target reduced by TD from C$52.00 to C$51.00. TD currently has a buy rating on the stock.

Saputo (TSE:SAP) had its target price raised by Ventum Capital from C$47.00 to C$48.00. They currently have a buy rating on the stock.

Transcontinental (TSE:TCL.A) had its target price trimmed by Royal Bank Of Canada from C$9.00 to C$8.00. Royal Bank Of Canada currently has an outperform rating on the stock.

Tango Therapeutics (NASDAQ:TNGX) had its price target increased by Leerink Partners from $55.00 to $69.00. They currently have an outperform rating on the stock.

UnitedHealth Group (NYSE:UNH) had its target price raised by Mizuho from $440.00 to $460.00. The firm currently has an outperform rating on the stock.